However, case reports also exist of LCNEC patients who, despite negative PD‐L1 expression by immunohistochemistry, exhibited positive mutations in genes such as RB1 and TP53, along with a high TMB (24.76 mut/Mb). This evidence concerns the gene TP53 and large cell neuroendocrine carcinoma.